A retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumors

Abstract Background To retrospectively investigate reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors (MOGCT) and sex cord-stromal tumors (SCST). Methods Data from 32 MOGCT (6 dysgerminomas, 6 yolk sac tumors, 17 immatu...

Full description

Bibliographic Details
Main Authors: Ning Zhang, Ruifang Chen, Keqin Hua, Ying Zhang
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Journal of Ovarian Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13048-017-0348-x
id doaj-ce5c06a8a59248c39c92dd51d8d5f4ae
record_format Article
spelling doaj-ce5c06a8a59248c39c92dd51d8d5f4ae2020-11-24T23:44:14ZengBMCJournal of Ovarian Research1757-22152017-07-011011510.1186/s13048-017-0348-xA retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumorsNing Zhang0Ruifang Chen1Keqin Hua2Ying Zhang3Department of Gynecology, The Obstetrics and Gynecology Hospital of Fudan UniversityDepartment of Gynecology, The Obstetrics and Gynecology Hospital of Fudan UniversityDepartment of Gynecology, The Obstetrics and Gynecology Hospital of Fudan UniversityDepartment of Gynecology, The Obstetrics and Gynecology Hospital of Fudan UniversityAbstract Background To retrospectively investigate reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors (MOGCT) and sex cord-stromal tumors (SCST). Methods Data from 32 MOGCT (6 dysgerminomas, 6 yolk sac tumors, 17 immature teratomas, and 3 mixed germ cell tumors) and 9 SCST (4 granulosa cell tumors and 5 sertoli-leydig cell tumors) aged from 18 to 35, treated in the Obstetrics and Gynecology Hospital of Fudan University from October 2003 to October 2013 were collected and analyzed. Results Average follow up was (86.3 ± 34.4) months. Average diagnosed age was (25.3 ± 3.5) years. Average chemotherapy course was (4.4 ± 1.3) times. Patients are all living. Thirty one patients (75.6%) reported normal menstrual cycles. Twelve patients (29.3%) wished to conceive, 10 (83.3%) naturally conceived and 8 (66.7%) had lived birth. Conclusions Reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in MOGCT and SCST are favorable, meanwhile education and consultation is needed.http://link.springer.com/article/10.1186/s13048-017-0348-xMalignant germ cell tumorsMalignant sex cord-stromal tumorsFertility-sparing surgeryPostoperative adjuvant chemotherapyReproductive outcomes
collection DOAJ
language English
format Article
sources DOAJ
author Ning Zhang
Ruifang Chen
Keqin Hua
Ying Zhang
spellingShingle Ning Zhang
Ruifang Chen
Keqin Hua
Ying Zhang
A retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumors
Journal of Ovarian Research
Malignant germ cell tumors
Malignant sex cord-stromal tumors
Fertility-sparing surgery
Postoperative adjuvant chemotherapy
Reproductive outcomes
author_facet Ning Zhang
Ruifang Chen
Keqin Hua
Ying Zhang
author_sort Ning Zhang
title A retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumors
title_short A retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumors
title_full A retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumors
title_fullStr A retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumors
title_full_unstemmed A retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumors
title_sort retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumors
publisher BMC
series Journal of Ovarian Research
issn 1757-2215
publishDate 2017-07-01
description Abstract Background To retrospectively investigate reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors (MOGCT) and sex cord-stromal tumors (SCST). Methods Data from 32 MOGCT (6 dysgerminomas, 6 yolk sac tumors, 17 immature teratomas, and 3 mixed germ cell tumors) and 9 SCST (4 granulosa cell tumors and 5 sertoli-leydig cell tumors) aged from 18 to 35, treated in the Obstetrics and Gynecology Hospital of Fudan University from October 2003 to October 2013 were collected and analyzed. Results Average follow up was (86.3 ± 34.4) months. Average diagnosed age was (25.3 ± 3.5) years. Average chemotherapy course was (4.4 ± 1.3) times. Patients are all living. Thirty one patients (75.6%) reported normal menstrual cycles. Twelve patients (29.3%) wished to conceive, 10 (83.3%) naturally conceived and 8 (66.7%) had lived birth. Conclusions Reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in MOGCT and SCST are favorable, meanwhile education and consultation is needed.
topic Malignant germ cell tumors
Malignant sex cord-stromal tumors
Fertility-sparing surgery
Postoperative adjuvant chemotherapy
Reproductive outcomes
url http://link.springer.com/article/10.1186/s13048-017-0348-x
work_keys_str_mv AT ningzhang aretrospectivestudyofreproductiveoutcomesafterfertilitysparingsurgeryandpostoperativeadjuvantchemotherapyinmalignantovariangermcelltumorsandsexcordstromaltumors
AT ruifangchen aretrospectivestudyofreproductiveoutcomesafterfertilitysparingsurgeryandpostoperativeadjuvantchemotherapyinmalignantovariangermcelltumorsandsexcordstromaltumors
AT keqinhua aretrospectivestudyofreproductiveoutcomesafterfertilitysparingsurgeryandpostoperativeadjuvantchemotherapyinmalignantovariangermcelltumorsandsexcordstromaltumors
AT yingzhang aretrospectivestudyofreproductiveoutcomesafterfertilitysparingsurgeryandpostoperativeadjuvantchemotherapyinmalignantovariangermcelltumorsandsexcordstromaltumors
AT ningzhang retrospectivestudyofreproductiveoutcomesafterfertilitysparingsurgeryandpostoperativeadjuvantchemotherapyinmalignantovariangermcelltumorsandsexcordstromaltumors
AT ruifangchen retrospectivestudyofreproductiveoutcomesafterfertilitysparingsurgeryandpostoperativeadjuvantchemotherapyinmalignantovariangermcelltumorsandsexcordstromaltumors
AT keqinhua retrospectivestudyofreproductiveoutcomesafterfertilitysparingsurgeryandpostoperativeadjuvantchemotherapyinmalignantovariangermcelltumorsandsexcordstromaltumors
AT yingzhang retrospectivestudyofreproductiveoutcomesafterfertilitysparingsurgeryandpostoperativeadjuvantchemotherapyinmalignantovariangermcelltumorsandsexcordstromaltumors
_version_ 1725499461795315712